Gilead Sciences (NASDAQ:GILD) Receives “Hold” Rating from Needham & Company LLC
Needham & Company LLC reiterated their hold rating on shares of Gilead Sciences (NASDAQ:GILD – Free Report) in a report published on Wednesday,Benzinga reports. Several other equities analysts have also recently weighed in on GILD. Royal Bank of Canada lifted their price objective on Gilead Sciences from $84.00 to $90.00 and gave the company a […]
Needham & Company LLC reiterated their hold rating on shares of Gilead Sciences (NASDAQ:GILD – Free Report) in a report published on Wednesday,Benzinga reports. Several other equities analysts have also recently weighed in on GILD. Royal Bank of Canada lifted their price objective on Gilead Sciences from $84.00 to $90.00 and gave the company a […]
